Clinical trial
Early Intervention Effectiveness of Tiotropium / Olodaterol Compared to Tiotropium in COPD
NCT04249310 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Intervention Effectiveness of Tiotropium / Olodaterol Compared to Tiotropium in COPD
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 27, 2020
- Completion date
- August 12, 2020
- Enrollment
- 6,788 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.